B9636

S-Benzoylthiamine O-monophosphate

• Synonyme(s) : Benfotiamine
• Formule empirique (notation de Hill) : C₁₉H₂₃N₄O₆PS
• Numéro CAS: 22457-89-2
• Poids moléculaire : 466.45
• NACRES: NA.79
• PubChem Substance ID: 24892147
• UNSPSC Code: 12352116
• EC Number: 245-013-4
• MDL number: MFCD00057343

Propriétés

• assay: ≥98% (TLC)
• Quality Segment: 200
• form: powder or crystals
• color: white to off-white
• storage temp.: 2-8°C
• SMILES string: Cc1ncc(CN(C=O)\C(C)=C(/CCOP(O)(O)=O)SC(=O)c2ccccc2)c(N)n1
• InChI: 1S/C19H23N4O6PS/c1-13(23(12-24)11-16-10-21-14(2)22-18(16)20)17(8-9-29-30(26,27)28)31-19(25)15-6-4-3-5-7-15/h3-7,10,12H,8-9,11H2,1-2H3,(H2,20,21,22)(H2,26,27,28)/b17-13+
• InChI key: BTNNPSLJPBRMLZ-GHRIWEEISA-N

Description

General description

S-Benzoylthiamine O-monophosphate (Benfotiamine) is an amphiphilic S-acyl thiamine derivative. It is a lipid-soluble vitamin. Benfotiamine contains a thiazole ring. Benfotiamine has a greater bioavailability than thiamine.

Application

S-Benzoylthiamine O-monophosphate has been used to determine its effect on ischemia and reperfusion in skeletal muscles of rat.

Biochem/physiol Actions

S-Benzoylthiamine O-monophosphate (Benfotiamine) is a therapeutic agent. It helps in the prevention of diabetic complications such as, retinopathy, neuropathy and nephropathy. Benfotiamine inhibits the synthesis of glycation end products (AGEs) in diabetes. Benfotiamine is considered as a nutraceutical product for the prevention of diabetic neuropathy.

Informations sur la sécurité

• Classe de stockage: 11 - Combustible Solids
• wgk: WGK 2
• flash_point_f: Not applicable
• flash_point_c: Not applicable
• ppe: Eyeshields, Gloves, type N95 (US)